Targeting the hypoxia-inducible factor (HIF) pathway in cancer
- PMID: 19709449
- DOI: 10.1017/S1462399409001173
Targeting the hypoxia-inducible factor (HIF) pathway in cancer
Abstract
The central component of hypoxia sensing in the cell is the hypoxia-inducible factor (HIF) transcriptional complex. HIF activity is deregulated in many human cancers, especially those that are highly hypoxic. Hypoxic tumour cells are usually resistant to radiotherapy and most conventional chemotherapeutic agents, rendering them highly aggressive and metastatic. Overexpression of HIF-alpha, the regulatory subunit of HIF, is associated with increased vascular density, severity of tumour grade, treatment failure and a poor prognostic outcome with conventional therapies. Therefore HIF is an attractive, although challenging, therapeutic target, and several different strategies have been developed to target HIF directly or indirectly in recent years. This review outlines the preclinical and clinical advances in this arena and discusses which cancers may benefit from HIF-targeted therapy.
Similar articles
-
Role of hypoxia-inducible factor-1alpha as a cancer therapy target.Endocr Relat Cancer. 2006 Dec;13 Suppl 1:S61-75. doi: 10.1677/erc.1.01290. Endocr Relat Cancer. 2006. PMID: 17259560 Review.
-
Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.J Exp Clin Cancer Res. 2007 Mar;26(1):39-50. J Exp Clin Cancer Res. 2007. PMID: 17550131 Review.
-
Targeting hypoxia cell signaling for cancer therapy.Cancer Metastasis Rev. 2007 Jun;26(2):341-52. doi: 10.1007/s10555-007-9059-x. Cancer Metastasis Rev. 2007. PMID: 17415529 Review.
-
Inhibiting hypoxia-inducible factor 1 for cancer therapy.Mol Cancer Res. 2006 Sep;4(9):601-5. doi: 10.1158/1541-7786.MCR-06-0235. Epub 2006 Aug 28. Mol Cancer Res. 2006. PMID: 16940159 Review.
-
Casein kinase 2 inhibition decreases hypoxia-inducible factor-1 activity under hypoxia through elevated p53 protein level.J Cell Sci. 2006 Aug 15;119(Pt 16):3351-62. doi: 10.1242/jcs.03069. Epub 2006 Aug 1. J Cell Sci. 2006. PMID: 16882692
Cited by
-
Atlas on substrate recognition subunits of CRL2 E3 ligases.Oncotarget. 2016 Jul 19;7(29):46707-46716. doi: 10.18632/oncotarget.8732. Oncotarget. 2016. PMID: 27107416 Free PMC article. Review.
-
Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism.Cells. 2019 Mar 3;8(3):214. doi: 10.3390/cells8030214. Cells. 2019. PMID: 30832409 Free PMC article. Review.
-
CHCHD4 Regulates Intracellular Oxygenation and Perinuclear Distribution of Mitochondria.Front Oncol. 2017 Apr 27;7:71. doi: 10.3389/fonc.2017.00071. eCollection 2017. Front Oncol. 2017. PMID: 28497026 Free PMC article.
-
Hypoxia A Typical Target in Human Lung Cancer Therapy.Curr Protein Pept Sci. 2024;25(5):376-385. doi: 10.2174/0113892037252820231114045234. Curr Protein Pept Sci. 2024. PMID: 38031268 Review.
-
Inhibition of the hypoxia-inducible factor pathway by a G-quadruplex binding small molecule.Sci Rep. 2013 Sep 30;3:2799. doi: 10.1038/srep02799. Sci Rep. 2013. PMID: 24165797 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources